Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This phase IV study aims to assess the safety and the efficacy in intra ocular pressure of
Geltim LP® 1 mg/g (0.1% unpreserved timolol maleate gel) in glaucomatous patients initially
treated and stabilised by monotherapy of Xalatan® with ocular objective signs of intolerance
to prostaglandin eye drops.